Dietmar Berger
2019
In 2019, Dietmar Berger earned a total compensation of $3.2M as Former Global Head of Research & Development at Atara Biotherapeutics, a 35% decrease compared to previous year.
Compensation breakdown
| Option Awards | $1,331,985 |
|---|---|
| Salary | $246,104 |
| Stock Awards | $1,529,200 |
| Other | $137,773 |
| Total | $3,245,062 |
Berger received $1.5M in stock awards, accounting for 47% of the total pay in 2019.
Berger also received $1.3M in option awards, $246.1K in salary and $137.8K in other compensation.
Rankings
In 2019, Dietmar Berger's compensation ranked 3,758th out of 13,971 executives tracked by ExecPay. In other words, Berger earned more than 73.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,758 out of 13,971 | 73rd |
Division Manufacturing | 1,361 out of 5,695 | 76th |
Major group Chemicals And Allied Products | 474 out of 2,194 | 78th |
Industry group Drugs | 398 out of 1,880 | 79th |
Industry Biological Products, Except Diagnostic Substances | 87 out of 389 | 78th |
Source: SEC filing on April 22, 2020.
Berger's colleagues
We found five more compensation records of executives who worked with Dietmar Berger at Atara Biotherapeutics in 2019.
2019
Isaac Ciechanover
Atara Biotherapeutics
Chief Executive Officer
2019
Pascal Touchon
Atara Biotherapeutics
Chief Executive Officer
2019
Joseph Newell
Atara Biotherapeutics
EVP, Chief Technical Operations Officer
2019
Utpal Koppikar
Atara Biotherapeutics
Chief Financial Officer
2019
Mina Kim
Atara Biotherapeutics